Eintrag weiter verarbeiten
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery fro...
Gespeichert in:
| Zeitschriftentitel: | OncoTargets and Therapy |
|---|---|
| Personen und Körperschaften: | , , , , |
| In: | OncoTargets and Therapy, Volume 12, 2019, S. 5545-5549 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Informa UK Limited
|
| Schlagwörter: |
| author_facet |
Wang, Hanping Zhang, Li Shi, Xiaohua Zhang, Xiaotong Si, Xiaoyan Wang, Hanping Zhang, Li Shi, Xiaohua Zhang, Xiaotong Si, Xiaoyan |
|---|---|
| author |
Wang, Hanping Zhang, Li Shi, Xiaohua Zhang, Xiaotong Si, Xiaoyan |
| spellingShingle |
Wang, Hanping Zhang, Li Shi, Xiaohua Zhang, Xiaotong Si, Xiaoyan OncoTargets and Therapy Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease Pharmacology (medical) Oncology |
| author_sort |
wang, hanping |
| spelling |
Wang, Hanping Zhang, Li Shi, Xiaohua Zhang, Xiaotong Si, Xiaoyan 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s204689 <p>Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease</p> OncoTargets and Therapy |
| doi_str_mv |
10.2147/ott.s204689 |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczIwNDY4OQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczIwNDY4OQ |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Informa UK Limited, 2019 |
| imprint_str_mv |
Informa UK Limited, 2019 |
| issn |
1178-6930 |
| issn_str_mv |
1178-6930 |
| language |
English |
| mega_collection |
Informa UK Limited (CrossRef) |
| match_str |
wang2019successfultreatmentwithosimertinibanditssubsequentresistancemechanisminapatientwithnonsmallcelllungcancerharboringacquiredegfrt790mmutationafterrecoveryfromac0010inducedinterstitiallungdisease |
| publishDateSort |
2019 |
| publisher |
Informa UK Limited |
| recordtype |
ai |
| record_format |
ai |
| series |
OncoTargets and Therapy |
| source_id |
49 |
| title |
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
|
| title_unstemmed |
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
|
| title_full |
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
|
| title_fullStr |
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
|
| title_full_unstemmed |
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
|
| title_short |
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
|
| title_sort |
<p>successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired egfr t790m mutation after recovery from ac0010-induced interstitial lung disease</p> |
| topic |
Pharmacology (medical) Oncology |
| url |
http://dx.doi.org/10.2147/ott.s204689 |
| publishDate |
2019 |
| physical |
5545-5549 |
| description |
|
| container_start_page |
5545 |
| container_title |
OncoTargets and Therapy |
| container_volume |
Volume 12 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792333032780201987 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:06:19.658Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Successful+treatment+with+osimertinib+and+its+subsequent+resistance+mechanism+in+a+patient+with+non-small-cell+lung+cancer+harboring+acquired+EGFR+T790M+mutation+after+recovery+from+AC0010-induced+interstitial+lung+disease%0A&rft.date=2019-07-01&genre=article&issn=1178-6930&volume=Volume+12&spage=5545&epage=5549&pages=5545-5549&jtitle=OncoTargets+and+Therapy&atitle=%3Cp%3ESuccessful+treatment+with+osimertinib+and+its+subsequent+resistance+mechanism+in+a+patient+with+non-small-cell+lung+cancer+harboring+acquired+EGFR+T790M+mutation+after+recovery+from+AC0010-induced+interstitial+lung+disease%3C%2Fp%3E&aulast=Si&aufirst=Xiaoyan&rft_id=info%3Adoi%2F10.2147%2Fott.s204689&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792333032780201987 |
| author | Wang, Hanping, Zhang, Li, Shi, Xiaohua, Zhang, Xiaotong, Si, Xiaoyan |
| author_facet | Wang, Hanping, Zhang, Li, Shi, Xiaohua, Zhang, Xiaotong, Si, Xiaoyan, Wang, Hanping, Zhang, Li, Shi, Xiaohua, Zhang, Xiaotong, Si, Xiaoyan |
| author_sort | wang, hanping |
| container_start_page | 5545 |
| container_title | OncoTargets and Therapy |
| container_volume | Volume 12 |
| description | |
| doi_str_mv | 10.2147/ott.s204689 |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczIwNDY4OQ |
| imprint | Informa UK Limited, 2019 |
| imprint_str_mv | Informa UK Limited, 2019 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1178-6930 |
| issn_str_mv | 1178-6930 |
| language | English |
| last_indexed | 2024-03-01T14:06:19.658Z |
| match_str | wang2019successfultreatmentwithosimertinibanditssubsequentresistancemechanisminapatientwithnonsmallcelllungcancerharboringacquiredegfrt790mmutationafterrecoveryfromac0010inducedinterstitiallungdisease |
| mega_collection | Informa UK Limited (CrossRef) |
| physical | 5545-5549 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Informa UK Limited |
| record_format | ai |
| recordtype | ai |
| series | OncoTargets and Therapy |
| source_id | 49 |
| spelling | Wang, Hanping Zhang, Li Shi, Xiaohua Zhang, Xiaotong Si, Xiaoyan 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s204689 <p>Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease</p> OncoTargets and Therapy |
| spellingShingle | Wang, Hanping, Zhang, Li, Shi, Xiaohua, Zhang, Xiaotong, Si, Xiaoyan, OncoTargets and Therapy, Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease , Pharmacology (medical), Oncology |
| title | Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease |
| title_full | Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease |
| title_fullStr | Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease |
| title_full_unstemmed | Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease |
| title_short | Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease |
| title_sort | <p>successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired egfr t790m mutation after recovery from ac0010-induced interstitial lung disease</p> |
| title_unstemmed | Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease |
| topic | Pharmacology (medical), Oncology |
| url | http://dx.doi.org/10.2147/ott.s204689 |